Biotech Newswire

Biotech Newswire

Comprehensive Real-Time News Feed for Biotech.

Results 1 - 20 of 515,799 in Biotech

  1. Johnson & Johnson (JNJ) Shares Sold by Middleton & Co Inc MARead the original story w/Photo

    6 min ago | Daily Political

    Middleton & Co Inc MA lowered its stake in shares of Johnson & Johnson by 1.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 38,787 shares of the company's stock after selling 485 shares during the period.

    Comment?

  2. Neumann Capital Management LLC Has $307,000 Holdings in PfizerRead the original story w/Photo

    6 min ago | Daily Political

    Neumann Capital Management LLC cut its holdings in Pfizer by 64.6% in the fourth quarter, Holdings Channel reports. The fund owned 8,483 shares of the biopharmaceutical company's stock after selling 15,450 shares during the quarter.

    Comment?

  3. Kapstone (KS) Upgraded to "Buy" by Zacks Investment ResearchRead the original story w/Photo

    8 min ago | Daily Political

    The brokerage currently has a $39.00 price target on the basic materials company's stock. Zacks Investment Research 's target price would indicate a potential upside of 12.36% from the company's current price.

    Comment?

  4. Gilead Sciences (GILD) Director Sells $440,741.48 in StockRead the original story w/Photo

    8 min ago | Daily Political

    Gilead Sciences Director John Francis Cogan sold 5,833 shares of the company's stock in a transaction dated Friday, April 13th. The shares were sold at an average price of $75.56, for a total transaction of $440,741.48.

    Comment?

  5. Omeros (OMER) Shares Bought by Teachers Advisors LLCRead the original story w/Photo

    9 min ago | Daily Political

    Teachers Advisors LLC increased its holdings in shares of Omeros by 7.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 80,820 shares of the biopharmaceutical company's stock after buying an additional 5,355 shares during the quarter.

    Comment?

  6. Gilead Sciences (GILD) Shares Sold by Two Sigma Advisers LPRead the original story w/Photo

    9 min ago | AmericanBankingNews.com

    Two Sigma Advisers LP reduced its position in shares of Gilead Sciences by 77.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 748,582 shares of the biopharmaceutical company's stock after selling 2,558,687 shares during the period.

    Comment?

  7. Tiaa Cref Investment Management LLC Decreases Holdings in Opko HealthRead the original story w/Photo

    11 min ago | Daily Political

    TIAA CREF Investment Management LLC trimmed its position in shares of OPKO Health by 4.2% during the fourth quarter, HoldingsChannel reports. The firm owned 1,011,881 shares of the biotechnology company's stock after selling 44,279 shares during the quarter.

    Comment?

  8. Catalyst Pharmaceuticals (CPRX) Position Increased by Renaissance Technologies LLCRead the original story w/Photo

    12 min ago | Daily Political

    Renaissance Technologies LLC lifted its position in Catalyst Pharmaceuticals by 91.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,114,100 shares of the biopharmaceutical company's stock after buying an additional 532,500 shares during the period.

    Comment?

  9. Glenmede Trust Co. NA Has $81.40 Million Holdings in CelgeneRead the original story w/Photo

    14 min ago | AmericanBankingNews.com

    Glenmede Trust Co. NA trimmed its position in shares of Celgene by 2.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission.

    Comment?

  10. CoreSite (COR) to Release Earnings on ThursdayRead the original story w/Photo

    14 min ago | AmericanBankingNews.com

    CoreSite will be posting its quarterly earnings results before the market opens on Thursday, April 26th. Analysts expect CoreSite to post earnings of $0.55 per share for the quarter.

    Comment?

  11. Bristol-Myers Squibb's (BMY) Outperform Rating Reaffirmed at William BlairRead the original story w/Photo

    15 min ago | Daily Political

    's stock had its "outperform" rating reiterated by research analysts at William Blair in a report released on Tuesday. William Blair also issued estimates for Bristol-Myers Squibb's Q4 2018 earnings at $0.76 EPS, FY2018 earnings at $3.18 EPS, Q1 2019 earnings at $0.83 EPS, Q2 2019 earnings at $0.85 EPS, Q3 2019 earnings at $0.88 EPS, Q4 2019 earnings at $0.90 EPS, FY2019 earnings at $3.46 EPS and FY2020 earnings at $4.11 EPS.

    Comment?

  12. Millennium Management LLC Purchases New Holdings in Acorda TherapeuticsRead the original story w/Photo

    16 min ago | AmericanBankingNews.com

    Millennium Management LLC purchased a new position in shares of Acorda Therapeutics in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 198,804 shares of the biopharmaceutical company's stock, valued at approximately $4,264,000.

    Comment?

  13. Mission Wealth Management LP Has $1.41 Million Holdings in Merck & Co.Read the original story w/Photo

    17 min ago | AmericanBankingNews.com

    Mission Wealth Management LP lowered its stake in shares of Merck & Co. by 8.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission.

    Comment?

  14. Brokerages Anticipate Ziopharm Oncology Inc (ZIOP) Will Announce Quarterly Sales of $1.55 MillionRead the original story w/Photo

    18 min ago | AmericanBankingNews.com

    Wall Street analysts expect Ziopharm Oncology Inc to post sales of $1.55 million for the current fiscal quarter, according to Zacks . Three analysts have issued estimates for Ziopharm Oncology's earnings, with the lowest sales estimate coming in at $1.46 million and the highest estimate coming in at $1.60 million.

    Comment?

  15. California State Teachers Retirement System Trims Stake in Gilead SciencesRead the original story w/Photo

    21 min ago | AmericanBankingNews.com

    California State Teachers Retirement System trimmed its stake in shares of Gilead Sciences by 0.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,213,504 shares of the biopharmaceutical company's stock after selling 17,085 shares during the period.

    Comment?

  16. Johnson & Johnson (JNJ) Shares Sold by Campbell Newman Asset Management Inc.Read the original story w/Photo

    21 min ago | AmericanBankingNews.com

    Campbell Newman Asset Management Inc. reduced its stake in Johnson & Johnson by 2.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,965 shares of the company's stock after selling 858 shares during the period.

    Comment?

  17. Guggenheim Capital LLC Takes Position in ImmunoGenRead the original story w/Photo

    23 min ago | AmericanBankingNews.com

    Guggenheim Capital LLC bought a new stake in ImmunoGen in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission . The fund bought 268,889 shares of the biotechnology company's stock, valued at approximately $1,724,000.

    Comment?

  18. AMAG Pharmaceuticals, Inc. (AMAG) Shares Bought by Geode Capital Management LLCRead the original story w/Photo

    23 min ago | AmericanBankingNews.com

    Geode Capital Management LLC raised its position in AMAG Pharmaceuticals, Inc. by 1.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 377,479 shares of the specialty pharmaceutical company's stock after purchasing an additional 5,452 shares during the quarter.

    Comment?

  19. Los Angeles Capital Management & Equity Research Inc. Has $68.93 ...Read the original story w/Photo

    23 min ago | AmericanBankingNews.com

    Los Angeles Capital Management & Equity Research Inc. trimmed its stake in Pfizer by 15.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,903,216 shares of the biopharmaceutical company's stock after selling 356,934 shares during the quarter.

    Comment?

  20. Lourd Capital LLC Has $2.99 Million Stake in Johnson & JohnsonRead the original story w/Photo

    24 min ago | AmericanBankingNews.com

    Lourd Capital LLC grew its stake in Johnson & Johnson by 116.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 21,384 shares of the company's stock after acquiring an additional 11,520 shares during the quarter.

    Comment?